A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo
Department of Medicine, Division of Dermatology; Department of Quantitative Health Sciences
Letter to the Editor
Dermatology | Skin and Connective Tissue Diseases | Translational Medical Research
We conducted a small, randomized, double-blind, placebo-controlled, phase II clinical trial to test simvastatin as a treatment for vitiligo.
Rights and Permissions
Citation: J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015. Link to article on publisher's site
Vanderweil, Stefan G.; Amano, Shinya U.; Ko, Wei-Che; Richmond, Jillian M.; Kelley, Michelle; Senna, Maryanne Makredes; Pearson, Andrea; Chowdary, Sandhya; Hartigan, Celia; Barton, Bruce A.; and Harris, John E., "A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo" (2017). UMass Center for Clinical and Translational Science Supported Publications. 103.